{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T13:51:23Z","timestamp":1776433883662,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,4,10]],"date-time":"2007-04-10T00:00:00Z","timestamp":1176163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,4,10]],"date-time":"2007-04-10T00:00:00Z","timestamp":1176163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00415-006-0481-8","type":"journal-article","created":{"date-parts":[[2007,4,9]],"date-time":"2007-04-09T14:12:54Z","timestamp":1176127974000},"page":"1026-1032","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["CSF neurofilament protein (NFL) \u2014 a marker of active HIV-related neurodegeneration"],"prefix":"10.1007","volume":"254","author":[{"given":"Sahra","family":"Abdulle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Mellgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,10]]},"reference":[{"key":"481_CR1","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1212\/WNL.44.10.1892","volume":"44","author":"Bacellar","year":"1994","unstructured":"Bacellar H, Munoz A, Miller EN, Cohen\nBA, Besley D, Selnes OA, Becker JT,\nMcArthur JC (1994) Temporal trends\nin the incidence of HIV-1-related neurologic\ndiseases: multicenter AIDS cohort\nstudy, 1985\u2013992. Neurology\n44:1892\u2013900","journal-title":"Neurology"},{"key":"481_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1097\/00002030-200307040-00015","volume":"17","author":"Dore","year":"2003","unstructured":"Dore GJ, McDonald A, Li Y, Kaldor JM,\nBrew BJ (2003) Marked improvement\nin survival following AIDS dementia\ncomplex in the era of highly active\nantiretroviral therapy. Aids 17:1539\u2013545","journal-title":"Aids"},{"key":"481_CR3","first-page":"S221","volume":"9","author":"Price","year":"1995","unstructured":"Price RW (1995) Management of AIDS\ndementia complex and HIV-1 infection\nof the nervous system. Aids 9(Suppl\nA):S221\u201336","journal-title":"Aids"},{"key":"481_CR4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-125-4-199608150-00001","volume":"125","author":"Schacker","year":"1996","unstructured":"Schacker T, Collier AC, Hughes J, Shea\nT, Corey L (1996) Clinical and epidemiologic\nfeatures of primary HIV\ninfection. Ann Intern Med 125:257\u201364","journal-title":"Ann Intern Med"},{"key":"481_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.410420503","volume":"42","author":"Ellis","year":"1997","unstructured":"Ellis RJ, Hsia K, Spector SA, Nelson JA,\nHeaton RK, Wallace MR, Abramson I,\nAtkinson JH, Grant I, McCutchan JA\n(1997) Cerebrospinal fluid human\nimmunodeficiency virus type 1 RNA\nlevels are elevated in neurocognitively\nimpaired individuals with acquired\nimmunodeficiency syndrome. HIV\nNeurobehavioral Research Center\nGroup. Ann Neurol 42:679\u201388","journal-title":"Ann Neurol"},{"key":"481_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-199908010-00003","volume":"21","author":"Gisslen","year":"1999","unstructured":"Gisslen M, Fuchs D, Svennerholm B,\nHagberg L (1999) Cerebrospinal fluid\nviral load, intrathecal immunoactivation,\nand cerebrospinal fluid monocytic\ncell count in HIV-1 infection. J Acquir\nImmune Defic Syndr 21:271\u201376","journal-title":"J Acquir Immune Defic Syndr"},{"key":"481_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410420504","volume":"42","author":"McArthur","year":"1997","unstructured":"McArthur JC, McClernon DR, Cronin\nMF, Nance-Sproson TE, Saah AJ, St\nClair M, Lanier ER (1997) Relationship\nbetween human immunodeficiency\nvirus-associated dementia and viral\nload in cerebrospinal fluid and brain.\nAnn Neurol 42:689\u201398","journal-title":"Ann Neurol"},{"key":"481_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2334-5-98","volume":"5","author":"Spudich","year":"2005","unstructured":"Spudich SS, Nilsson AC, Lollo ND,\nLiegler TJ, Petropoulos CJ, Deeks SG,\nPaxinos EE, Price RW (2005) Cerebrospinal\nfluid HIV infection and pleocytosis:\nRelation to systemic infection\nand antiretroviral treatment. BMC Infect\nDis 5:98","journal-title":"BMC Infect Dis"},{"key":"481_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ana.410280413","volume":"28","author":"Brew","year":"1990","unstructured":"Brew BJ, Bhalla RB, Paul M, Gallardo H,\nMcArthur JC, Schwartz MK, Price RW\n(1990) Cerebrospinal fluid neopterin in\nhuman immunodeficiency virus type 1\ninfection. Ann Neurol 28:556\u201360","journal-title":"Ann Neurol"},{"key":"481_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1086\/514001","volume":"175","author":"Brew","year":"1997","unstructured":"Brew BJ, Pemberton L, Cunningham P,\nLaw MG (1997) Levels of human\nimmunodeficiency virus type 1 RNA in\ncerebrospinal fluid correlate with AIDS\ndementia stage. J Infect Dis 175:963\u201366","journal-title":"J Infect Dis"},{"key":"481_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jnr.1242","volume":"66","author":"Sjogren","year":"2001","unstructured":"Sjogren M, Blomberg M, Jonsson M,\nWahlund LO, Edman A, Lind K,\nRosengren L, Blennow K, Wallin A\n(2001) Neurofilament protein in cerebrospinal\nfluid: a marker of white\nmatter changes. J Neurosci Res 66:510\u201316","journal-title":"J Neurosci Res"},{"key":"481_CR12","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","volume":"61","author":"Malmestrom","year":"2003","unstructured":"Malmestrom C, Haghighi S, Rosengren\nL, Andersen O, Lycke J (2003) Neurofilament\nlight protein and glial fibrillary\nacidic protein as biological markers in\nMS. Neurology 61:1720\u2013725","journal-title":"Neurology"},{"key":"481_CR13","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"Rosengren","year":"1996","unstructured":"Rosengren LE, Karlsson JE, Karlsson\nJO, Persson LI, Wikkelso C (1996) Patients\nwith amyotrophic lateral sclerosis\nand other neurodegenerative\ndiseases have increased levels of neurofilament\nprotein in CSF. J Neurochem\n67:2013\u2013018","journal-title":"J Neurochem"},{"key":"481_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0165-5728(99)00150-2","volume":"102","author":"Hagberg","year":"2000","unstructured":"Hagberg L, Fuchs D, Rosengren L,\nGisslen M (2000) Intrathecal immune\nactivation is associated with cerebrospinal\nfluid markers of neuronal\ndestruction in AIDS patients. J Neuroimmunol\n102:51\u20135","journal-title":"J Neuroimmunol"},{"key":"481_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-6405-2-6","volume":"2","author":"Gisslen","year":"2005","unstructured":"Gisslen M, Rosengren L, Hagberg L,\nDeeks SG, Price RW (2005) Cerebrospinal\nfluid signs of neuronal damage\nafter antiretroviral treatment interruption\nin HIV-1 infection. AIDS Res Ther\n2:6","journal-title":"AIDS Res Ther"},{"key":"481_CR16","unstructured":"(1992) 1993 revised classification system\nfor HIV infection and expanded\nsurveillance case definition for AIDS\namong adolescents and adults. MMWR\nRecomm Rep 41:1\u20139"},{"key":"481_CR17","doi-asserted-by":"crossref","unstructured":"(1991) Nomenclature and research case\ndefinitions for neurologic manifestations\nof human immunodeficiency\nvirus-type 1 (HIV-1) infection. Report\nof a Working Group of the American\nAcademy of Neurology AIDS Task\nForce. Neurology 41:778\u201385","DOI":"10.1212\/WNL.41.6.778"},{"key":"481_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/13550289809113490","volume":"4","author":"Cinque","year":"1998","unstructured":"Cinque P, Cleator GM, Weber T,\nMonteyne P, Sindic C, Gerna G, van\nLoon AM, Klapper PE (1998) Diagnosis\nand clinical management of neurological\ndisorders caused by cytomegalovirus\nin AIDS patients. European Union\nConcerted Action on Virus Meningitis\nand Encephalitis. J Neurovirol 4:120\u201332","journal-title":"J Neurovirol"},{"key":"481_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0166-0934(97)00152-3","volume":"69","author":"Weber","year":"1997","unstructured":"Weber T, Klapper PE, Cleator GM,\nBodemer M, Luke W, Knowles W,\nCinque P, Van Loon AM, Grandien M,\nHammarin AL, Ciardi M, Bogdanovic G\n(1997) Polymerase chain reaction for\ndetection of JC virus DNA in cerebrospinal\nfluid: a quality control study.\nEuropean Union concerted action on\nviral meningitis and encephalitis.\nJ Virol Methods 69:231\u201337","journal-title":"J Virol Methods"},{"key":"481_CR20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/infdis\/158.5.1079","volume":"158","author":"Price","year":"1988","unstructured":"Price RW, Brew BJ (1988) The AIDS\ndementia complex. J Infect Dis\n158:1079\u2013083","journal-title":"J Infect Dis"},{"key":"481_CR21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1515\/pteridines.2004.15.3.102","volume":"15","author":"Hagberg","year":"2004","unstructured":"Hagberg L, Andersson L-M, Abdulle S,\nGisslen M (2004) Clinical application of\ncerebrospinal fluid neopterin concentrations\nin HIV infection. Pteridines\n15:102\u201306","journal-title":"Pteridines"},{"key":"481_CR22","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1097\/00002030-199909100-00011","volume":"13","author":"Price","year":"1999","unstructured":"Price RW, Yiannoutsos CT, Clifford\nDB, Zaborski L, Tselis A, Sidtis JJ, Cohen\nB, Hall CD, Erice A, Henry K\n(1999) Neurological outcomes in late\nHIV infection: adverse impact of neurological\nimpairment on survival and\nprotective effect of antiviral therapy.\nAIDS Clinical Trial Group and Neurological\nAIDS Research Consortium\nstudy team. Aids 13:1677\u2013685","journal-title":"Aids"},{"key":"481_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.410380404","volume":"38","author":"Brew","year":"1995","unstructured":"Brew BJ, Rosenblum M, Cronin K,\nPrice RW (1995) AIDS dementia complex\nand HIV-1 brain infection: clinical-virological correlations. Ann\nNeurol 38:563\u201370","journal-title":"Ann Neurol"},{"key":"481_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.410190602","volume":"19","author":"Navia","year":"1986","unstructured":"Navia BA, Jordan BD, Price RW (1986)\nThe AIDS dementia complex: I. Clinical\nfeatures. Ann Neurol 19:517\u201324","journal-title":"Ann Neurol"},{"key":"481_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev.neuro.25.112701.142822","volume":"25","author":"Williams","year":"2002","unstructured":"Williams KC, Hickey WF (2002) Central\nnervous system damage, monocytes\nand macrophages, and\nneurological disorders in AIDS. Annu\nRev Neurosci 25:537\u201362","journal-title":"Annu Rev Neurosci"},{"key":"481_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.10827","volume":"55","author":"d'Arminio Monforte","year":"2004","unstructured":"d'Arminio Monforte A, Cinque P, Mocroft\nA, Goebel FD, Antunes F, Katlama\nC, Justesen US, Vella S, Kirk O, Lundgren\nJ (2004) Changing incidence of\ncentral nervous system diseases in the\nEuroSIDA cohort. Ann Neurol 55:320\u201328","journal-title":"Ann Neurol"},{"key":"481_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/13550280490521078","volume":"10","author":"Cysique","year":"2004","unstructured":"Cysique LA, Maruff P, Brew BJ (2004)\nPrevalence and pattern of neuropsychological\nimpairment in human\nimmunodeficiency virus-infected\/acquired\nimmunodeficiency syndrome\n(HIV\/AIDS) patients across pre- and\npost-highly active antiretroviral therapy\neras: a combined study of two cohorts.\nJ Neurovirol 10:350\u201357","journal-title":"J Neurovirol"},{"key":"481_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1089\/aid.2005.21.706","volume":"21","author":"Tozzi","year":"2005","unstructured":"Tozzi V, Balestra P, Serraino D, Bellagamba\nR, Corpolongo A, Piselli P, Lorenzini\nP, Visco-Comandini U, Vlassi\nC, Quartuccio ME, Giulianelli M, Noto\nP, Galgani S, Ippolito G, Antinori A,\nNarciso P (2005) Neurocognitive\nimpairment and survival in a cohort of\nHIV-infected patients treated with\nHAART. AIDS Res Hum Retroviruses\n21:706\u201313","journal-title":"AIDS Res Hum Retroviruses"},{"key":"481_CR29","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/00002030-200401001-00011","volume":"18","author":"Brew","year":"2004","unstructured":"Brew BJ (2004) Evidence for a change\nin AIDS dementia complex in the era of\nhighly active antiretroviral therapy and\nthe possibility of new forms of AIDS\ndementia complex. Aids 18(Suppl\n1):S75\u20138","journal-title":"Aids"},{"key":"481_CR30","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/00002030-199811000-00014","volume":"12","author":"Cinque","year":"1998","unstructured":"Cinque P, Vago L, Mengozzi M, Torri\nV, Ceresa D, Vicenzi E, Transidico P,\nVagani A, Sozzani S, Mantovani A,\nLazzarin A, Poli G (1998) Elevated\ncerebrospinal fluid levels of monocyte\nchemotactic protein-1 correlate with\nHIV-1 encephalitis and local viral replication.\nAids 12:1327\u2013332","journal-title":"Aids"},{"key":"481_CR31","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1086\/520301","volume":"26","author":"Bossi","year":"1998","unstructured":"Bossi P, Dupin N, Coutellier A, Bricaire\nF, Lubetzki C, Katlama C, Calvez V\n(1998) The level of human immunodeficiency\nvirus (HIV) type 1 RNA in\ncerebrospinal fluid as a marker of HIV\nencephalitis. Clin Infect Dis 26:1072\u2013073","journal-title":"Clin Infect Dis"},{"key":"481_CR32","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1073\/pnas.84.10.3472","volume":"84","author":"Hoffman","year":"1987","unstructured":"Hoffman PN, Cleveland DW, Griffin\nJW, Landes PW, Cowan NJ, Price DL\n(1987) Neurofilament gene expression:\na major determinant of axonal caliber.\nProc Natl Acad Sci USA 84:3472\u2013476","journal-title":"Proc Natl Acad Sci USA"},{"key":"481_CR33","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/080352501317061594","volume":"90","author":"Blennow","year":"2001","unstructured":"Blennow M, Savman K, Ilves P, Thoresen\nM, Rosengren L (2001) Brainspecific\nproteins in the cerebrospinal\nfluid of severely asphyxiated newborn\ninfants. Acta Paediatr 90:1171\u2013175","journal-title":"Acta Paediatr"},{"key":"481_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2004.03.003","volume":"221","author":"Rosen","year":"2004","unstructured":"Rosen H, Karlsson JE, Rosengren L\n(2004) CSF levels of neurofilament is a\nvaluable predictor of long-term outcome\nafter cardiac arrest. J Neurol Sci\n221:19\u20134","journal-title":"J Neurol Sci"},{"key":"481_CR35","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000142988.49341.D1","volume":"63","author":"Norgren","year":"2004","unstructured":"Norgren N, Sundstrom P, Svenningsson\nA, Rosengren L, Stigbrand T,\nGunnarsson M (2004) Neurofilament\nand glial fibrillary acidic protein in\nmultiple sclerosis. Neurology 63:1586\u2013590","journal-title":"Neurology"},{"key":"481_CR36","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.52.5.1090","volume":"52","author":"Rosengren","year":"1999","unstructured":"Rosengren LE, Karlsson JE, Sjogren M,\nBlennow K, Wallin A (1999) Neurofilament\nprotein levels in CSF are increased\nin dementia. Neurology\n52:1090\u2013093","journal-title":"Neurology"},{"key":"481_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/15368590252917647","volume":"21","author":"Norgren","year":"2002","unstructured":"Norgren N, Karlsson JE, Rosengren L,\nStigbrand T (2002) Monoclonal antibodies\nselective for low molecular\nweight neurofilaments. Hybrid Hybridomics\n21:53\u20139","journal-title":"Hybrid Hybridomics"},{"key":"481_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","volume":"987","author":"Norgren","year":"2003","unstructured":"Norgren N, Rosengren L, Stigbrand T\n(2003) Elevated neurofilament levels in\nneurological diseases. Brain Res\n987:25\u20131","journal-title":"Brain Res"},{"key":"481_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jim.2004.11.015","volume":"296","author":"Van Geel","year":"2005","unstructured":"Van Geel WJ, Rosengren LE, Verbeek\nMM (2005) An enzyme immunoassay\nto quantify neurofilament light chain in\ncerebrospinal fluid. J Immunol Methods\n296:179\u201385","journal-title":"J Immunol Methods"},{"key":"481_CR40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1084\/jem.160.1.310","volume":"160","author":"Huber","year":"1984","unstructured":"Huber C, Batchelor JR, Fuchs D, Hausen\nA, Lang A, Niederwieser D, Reibnegger\nG, Swetly P, Troppmair J,\nWachter H (1984) Immune responseassociated\nproduction of neopterin.\nRelease from macrophages primarily\nunder control of interferon-gamma. J\nExp Med 160:310\u201316","journal-title":"J Exp Med"},{"key":"481_CR41","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1128\/JVI.79.13.7959-7966.2005","volume":"79","author":"Harrington","year":"2005","unstructured":"Harrington PR, Haas DW, Ritola K,\nSwanstrom R (2005) Compartmentalized\nhuman immunodeficiency virus\ntype 1 present in cerebrospinal fluid is\nproduced by short-lived cells. J Virol\n79:7959\u2013966","journal-title":"J Virol"},{"key":"481_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/ana.410420502","volume":"42","author":"Price","year":"1997","unstructured":"Price RW, Staprans S (1997) Measuring\nthe \u201cviral load\u2013in cerebrospinal fluid\nin human immunodeficiency virus\ninfection: window into brain infection?\nAnn Neurol 42:675\u201378","journal-title":"Ann Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0481-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-006-0481-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0481-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0481-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T07:01:10Z","timestamp":1652598070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-006-0481-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,10]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s00415-006-0481-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,10]]},"assertion":[{"value":"1 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}